A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

Ambroxol supports a key enzyme called glucocerebrosidase (GCase), which is produced by the GBA1 gene. In people with Parkinson’s disease, GCase levels are often low.

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

“Ambroxol was safe, well-tolerated, and demonstrated target engagement,” scientists wrote, however adding that the drug’s clinical effect on cognition was “not confirmed” in the study.

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...